Shin Nippon Biomedical Laboratories, Ltd. (2395.T)
JPY 1537.0
(-1.22%)
JPY 1537.0
(-1.22%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 16.05 Billion JPY | 95.15% |
| 2022 | 8.22 Billion JPY | 227.87% |
| 2021 | 2.5 Billion JPY | -54.0% |
| 2020 | 5.45 Billion JPY | -43.6% |
| 2019 | 9.67 Billion JPY | -10.52% |
| 2018 | 10.8 Billion JPY | -20.63% |
| 2017 | 13.62 Billion JPY | -12.06% |
| 2016 | 15.48 Billion JPY | -11.0% |
| 2015 | 17.4 Billion JPY | 16.63% |
| 2014 | 14.92 Billion JPY | 24.57% |
| 2013 | 11.97 Billion JPY | -24.82% |
| 2012 | 15.93 Billion JPY | 6.49% |
| 2011 | 14.96 Billion JPY | 8.99% |
| 2010 | 13.72 Billion JPY | 11.13% |
| 2009 | 12.35 Billion JPY | 8.96% |
| 2008 | 11.33 Billion JPY | 47.49% |
| 2007 | 7.68 Billion JPY | 36.13% |
| 2006 | 5.64 Billion JPY | 166.01% |
| 2005 | 2.12 Billion JPY | -4.69% |
| 2004 | 2.22 Billion JPY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 22.38 Billion JPY | 39.42% |
| 2023 Q4 | 16.05 Billion JPY | 15.44% |
| 2023 Q2 | 11.42 Billion JPY | 13.76% |
| 2023 Q1 | 10.04 Billion JPY | 22.08% |
| 2023 Q3 | 13.9 Billion JPY | 21.73% |
| 2023 FY | 16.05 Billion JPY | 95.15% |
| 2022 Q3 | 7.82 Billion JPY | 19.3% |
| 2022 Q2 | 6.55 Billion JPY | 67.93% |
| 2022 Q1 | 3.9 Billion JPY | 55.6% |
| 2022 FY | 8.22 Billion JPY | 227.87% |
| 2022 Q4 | 8.22 Billion JPY | 5.18% |
| 2021 Q4 | 2.5 Billion JPY | -45.3% |
| 2021 Q2 | 5.34 Billion JPY | -17.87% |
| 2021 Q1 | 6.51 Billion JPY | 19.34% |
| 2021 FY | 2.5 Billion JPY | -54.0% |
| 2021 Q3 | 4.58 Billion JPY | -14.2% |
| 2020 Q3 | 7.64 Billion JPY | -17.21% |
| 2020 Q1 | 10.13 Billion JPY | 4.76% |
| 2020 Q2 | 9.23 Billion JPY | -8.84% |
| 2020 FY | 5.45 Billion JPY | -43.6% |
| 2020 Q4 | 5.45 Billion JPY | -28.67% |
| 2019 Q3 | 10.83 Billion JPY | 5.48% |
| 2019 FY | 9.67 Billion JPY | -10.52% |
| 2019 Q1 | 11.32 Billion JPY | 4.78% |
| 2019 Q2 | 10.27 Billion JPY | -9.3% |
| 2019 Q4 | 9.67 Billion JPY | -10.73% |
| 2018 FY | 10.8 Billion JPY | -20.63% |
| 2018 Q3 | 11.97 Billion JPY | -9.56% |
| 2018 Q2 | 13.24 Billion JPY | -3.19% |
| 2018 Q1 | 13.67 Billion JPY | 0.43% |
| 2018 Q4 | 10.8 Billion JPY | -9.74% |
| 2017 Q4 | 13.62 Billion JPY | -1.12% |
| 2017 Q3 | 13.77 Billion JPY | -9.19% |
| 2017 Q2 | 15.16 Billion JPY | -3.41% |
| 2017 Q1 | 15.7 Billion JPY | 1.41% |
| 2017 FY | 13.62 Billion JPY | -12.06% |
| 2016 Q1 | 17.36 Billion JPY | -0.19% |
| 2016 Q2 | 18.56 Billion JPY | 6.87% |
| 2016 FY | 15.48 Billion JPY | -11.0% |
| 2016 Q4 | 15.48 Billion JPY | -16.15% |
| 2016 Q3 | 18.47 Billion JPY | -0.5% |
| 2015 Q1 | 13.37 Billion JPY | -10.37% |
| 2015 Q3 | 16.47 Billion JPY | 12.98% |
| 2015 Q2 | 14.57 Billion JPY | 9.01% |
| 2015 FY | 17.4 Billion JPY | 16.63% |
| 2015 Q4 | 17.4 Billion JPY | 5.66% |
| 2014 Q3 | 14.24 Billion JPY | 0.51% |
| 2014 FY | 14.92 Billion JPY | 24.57% |
| 2014 Q4 | 14.92 Billion JPY | 4.73% |
| 2014 Q1 | 13.81 Billion JPY | 15.35% |
| 2014 Q2 | 14.17 Billion JPY | 2.59% |
| 2013 Q3 | 11.64 Billion JPY | -19.56% |
| 2013 Q2 | 14.47 Billion JPY | -18.19% |
| 2013 Q1 | 17.69 Billion JPY | 11.07% |
| 2013 FY | 11.97 Billion JPY | -24.82% |
| 2013 Q4 | 11.97 Billion JPY | 2.85% |
| 2012 Q1 | 15.29 Billion JPY | 2.2% |
| 2012 Q4 | 15.93 Billion JPY | -0.68% |
| 2012 Q3 | 16.04 Billion JPY | 1.55% |
| 2012 Q2 | 15.79 Billion JPY | 3.32% |
| 2012 FY | 15.93 Billion JPY | 6.49% |
| 2011 Q4 | 14.96 Billion JPY | -3.52% |
| 2011 Q3 | 15.5 Billion JPY | 7.31% |
| 2011 Q2 | 14.45 Billion JPY | 9.15% |
| 2011 Q1 | 13.24 Billion JPY | -3.55% |
| 2011 FY | 14.96 Billion JPY | 8.99% |
| 2010 FY | 13.72 Billion JPY | 11.13% |
| 2010 Q1 | 13.7 Billion JPY | 10.92% |
| 2010 Q2 | 14.02 Billion JPY | 2.34% |
| 2010 Q3 | 14.32 Billion JPY | 2.19% |
| 2010 Q4 | 13.72 Billion JPY | -4.2% |
| 2009 Q4 | 12.35 Billion JPY | -1.09% |
| 2009 FY | 12.35 Billion JPY | 8.96% |
| 2009 Q3 | 12.48 Billion JPY | -6.08% |
| 2009 Q2 | 13.29 Billion JPY | 0.0% |
| 2008 FY | 11.33 Billion JPY | 47.49% |
| 2008 Q4 | 11.33 Billion JPY | -19.83% |
| 2008 Q3 | 14.14 Billion JPY | 0.0% |
| 2007 FY | 7.68 Billion JPY | 36.13% |
| 2006 FY | 5.64 Billion JPY | 166.01% |
| 2005 FY | 2.12 Billion JPY | -4.69% |
| 2004 FY | 2.22 Billion JPY | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| DNA Chip Research Inc. | -388.4 Million JPY | 4233.895% |
| Cosmo Bio Company,Limited | -2.8 Billion JPY | 672.213% |
| H.U. Group Holdings, Inc. | 41.99 Billion JPY | 61.77% |
| FALCO HOLDINGS Co., Ltd. | -9.24 Billion JPY | 273.619% |
| BML, Inc. | -68.84 Billion JPY | 123.321% |
| Human Metabolome Technologies, Inc. | -1.56 Billion JPY | 1127.798% |
| Precision System Science Co., Ltd. | -548.58 Million JPY | 3026.846% |